Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02903914
Title Arginase Inhibitor CB-1158 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ESP


No variant requirements are available.